Pediatrics Doctors in Falmouth, MA Accepting Medicare

9 Pediatrics doctors found. Showing 1 - 9

Peter T Lind, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Bramblebush Park, Falmouth Pediatric Associates, Falmouth, MA 02540 Phone: 508-540-1801

Giannina Tierney, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15 Bramblebush Park, Falmouth, MA 02540 Phone: 508-548-6969    Fax: 508-540-2793

Barbara Rose Lowe, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15 Bramblebush Park, Falmouth, MA 02540 Phone: 508-548-6969    Fax: 508-540-2793

Dr. Kira Grant Edwards, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15 Bramblebush Park, Falmouth, MA 02540 Phone: 508-548-6969    Fax: 508-540-2793

Barbara Anne Hajjar, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 28 Cape Codder Rd, 109, Falmouth, MA 02540 Phone: 508-540-3146    Fax: 508-444-6304

Dr. Frank George Emerling, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Bramblebush Park, Falmouth, MA 02540 Phone: 508-540-1801    Fax: 508-540-6595

Emily O'connell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Bramble Bush Dr, Falmouth, MA 02540 Phone: 508-540-1801

Gregory W. Parkinson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Bramblebush Park, Falmouth, MA 02540 Phone: 508-540-1801    Fax: 508-540-6595

Richard Chris Adams, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 100 Ter Heun Dr, Falmouth, MA 02540 Phone: 508-457-3505    Fax: 508-457-3675

News Archive

Repligen licenses uridine patent rights for treatment of bipolar disorder

Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards.

Beta-blocker drugs may improve survival time for melanoma patients

Beta-blocker drugs, commonly used to treat high blood pressure, may also play a major role in slowing the progression of certain serious cancers, based on a new study.

Study: Children start to learn some aspects of reading, writing at very early age

Even the proudest of parents may struggle to find some semblance of meaning behind the seemingly random mish-mash of letters that often emerge from a toddler's first scribbled and scrawled attempts at putting words on paper.

Tendyne Feasibility Study: Tendyne successfully implants TMVI system in first patient

Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.

Read more Medical News

› Verified 9 days ago